|
|
||||||||
The Journal of Immunology, Vol 156, Issue 9 3374-3381, Copyright © 1996 by American Association of Immunologists
ARTICLES |
KL White, HL Snyder and U Krzych
Department of Biology, The Catholic University of America, Washington, DC 20064, USA.
T lymphocytes are believed to play a major role in protection against malaria. Previous experiments using in vivo depletion of CD8+ T cells, reconstitution with CD8+ T splenic cells, and adoptive transfer of CD8+ CTL clones demonstrated that protection against the exoerythrocytic stage of the murine strain, Plasmodium berghei malaria, was CD8+ T cell- dependent. Despite evidence for the critical role of CD8+ CTL, neither the cellular nor the molecular requirements for CD8+ T cell induction or for recognition of malaria Ags are known. In this study, we wished to define the role of CD8+ T cells and MHC class I molecules by using the P. berghei malaria attenuated sporozoites (SPZ) protection model in beta 2-microglobulin (beta 2m) knockout (-/-) mice. In contrast to observations that beta 2m-/- mice are resistant to many infectious diseases by compensatory mechanisms involving non-class I-restricted T cells, we found that beta 2m-/- mice failed to be protected against P. berghei SPZ, although immunization with attenuated SPZ induced production of IL-2, INF-gamma, anti-circumsporozoite protein IgG, and proliferative T cells. The lack of compensatory mechanisms involving non-CD8+ T cells was particularly evident in the failure to adoptively transfer protective immunity with wild-type SPZ-immune splenic T cells. From our data it can be concluded that CD8+ T cells induced during immunization with attenuated SPZ must recognize liver-expressed Ags presented by class I molecules to engage effectively in a response leading to destruction of the malaria parasites.
This article has been cited by other articles:
![]() |
G. A. Oliveira, K. A. Kumar, J. M. Calvo-Calle, C. Othoro, D. Altszuler, V. Nussenzweig, and E. H. Nardin Class II-Restricted Protective Immunity Induced by Malaria Sporozoites Infect. Immun., March 1, 2008; 76(3): 1200 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. Mueller, M. Deckert, K. Heiss, K. Goetz, K. Matuschewski, and D. Schluter Genetically Attenuated Plasmodium berghei Liver Stages Persist and Elicit Sterile Protection Primarily via CD8 T Cells Am. J. Pathol., July 1, 2007; 171(1): 107 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Bongfen, R. Torgler, J. F. Romero, L. Renia, and G. Corradin Plasmodium berghei-Infected Primary Hepatocytes Process and Present the Circumsporozoite Protein to Specific CD8+ T Cells In Vitro J. Immunol., June 1, 2007; 178(11): 7054 - 7063. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Calvo-Calle, G. A. Oliveira, C. O. Watta, J. Soverow, C. Parra-Lopez, and E. H. Nardin A Linear Peptide Containing Minimal T- and B-Cell Epitopes of Plasmodium falciparum Circumsporozoite Protein Elicits Protection against Transgenic Sporozoite Challenge Infect. Immun., December 1, 2006; 74(12): 6929 - 6939. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Berenzon, R. J. Schwenk, L. Letellier, M. Guebre-Xabier, J. Williams, and U. Krzych Protracted Protection to Plasmodium berghei Malaria Is Linked to Functionally and Phenotypically Heterogeneous Liver Memory CD8+ T Cells J. Immunol., August 15, 2003; 171(4): 2024 - 2034. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Weiss, W. W. Leitner, S. Scheiblhofer, D. Chen, A. Bernhaupt, S. Mostbock, J. Thalhamer, and J. A. Lyon Genetic Vaccination against Malaria Infection by Intradermal and Epidermal Injections of a Plasmid Containing the Gene Encoding the Plasmodium berghei Circumsporozoite Protein Infect. Immun., October 1, 2000; 68(10): 5914 - 5919. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. McKenna, M. Tsuji, M. Sarzotti, J. B. Sacci Jr., A. A. Witney, and A. F. Azad gamma delta T Cells Are a Component of Early Immunity against Preerythrocytic Malaria Parasites Infect. Immun., April 1, 2000; 68(4): 2224 - 2230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aidoo, A. Lalvani, S. C. Gilbert, J. T. Hu, P. Daubersies, N. Hurt, H. C. Whittle, P. Druihle, and A. V. S. Hill Cytotoxic T-Lymphocyte Epitopes for HLA-B53 and Other HLA Types in the Malaria Vaccine Candidate Liver-Stage Antigen 3 Infect. Immun., January 1, 2000; 68(1): 227 - 232. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Z. Mehal, A. E. Juedes, and I. N. Crispe Selective Retention of Activated CD8+ T Cells by the Normal Liver J. Immunol., September 15, 1999; 163(6): 3202 - 3210. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Vaughan, L. F. Scheller, R. A. Wirtz, and A. F. Azad Infectivity of Plasmodium berghei Sporozoites Delivered by Intravenous Inoculation versus Mosquito Bite: Implications for Sporozoite Vaccine Trials Infect. Immun., August 1, 1999; 67(8): 4285 - 4289. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |